Growth Metrics

Cullinan Therapeutics (CGEM) Other Working Capital Changes (2020 - 2023)

Cullinan Therapeutics has reported Other Working Capital Changes over the past 4 years, most recently at $3.3 million for Q4 2023.

  • Quarterly results put Other Working Capital Changes at $3.3 million for Q4 2023, up 428.73% from a year ago — trailing twelve months through Dec 2023 was $5.9 million (up 426.02% YoY), and the annual figure for FY2025 was -$6.9 million, down 379.0%.
  • Other Working Capital Changes for Q4 2023 was $3.3 million at Cullinan Therapeutics, down from $3.8 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CGEM hit a ceiling of $4.4 million in Q1 2021 and a floor of -$1.9 million in Q2 2023.
  • Median Other Working Capital Changes over the past 4 years was $598000.0 (2020), compared with a mean of $675312.5.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 2767.19% in 2021 and later soared 801.84% in 2023.
  • Cullinan Therapeutics' Other Working Capital Changes stood at -$64000.0 in 2020, then tumbled by 2767.19% to -$1.8 million in 2021, then skyrocketed by 133.95% to $623000.0 in 2022, then surged by 428.73% to $3.3 million in 2023.
  • The last three reported values for Other Working Capital Changes were $3.3 million (Q4 2023), $3.8 million (Q3 2023), and -$1.9 million (Q2 2023) per Business Quant data.